PRIMARY STUDY

Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review

Key Findings:  Current evidence is weak for the recommended use of cannabinoids in the treatment of urinary disorders such as neurogenic bladder dysfunction (clinical studies), renal disease (animal studies), and interstitial cystitis (animal studies). Further, high-quality research is recommended.

Type of Study:  Meta-analysis

Study Sample Size:  62

Study Result:  Inconclusive

Study Location(s):  United Kingdom

Year of Pub:  2021


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified